Quintiles and CROs

Guest: Dr. Raymond Huml, Executive Director of Strategic Drug Development and Head of Global Biosimilars Strategic Planning, Quintiles, Inc.
Topics: Quintiles, regulatory affairs, pharmaceutical due diligence, evolving business models in pharma and CROs, biosimilars

Humlphoto

Dr. Raymond Huml

Quintiles

Regulatory Affairs Professionals Society

Click to Download: Radio In Vivo March 12, 2014

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s